Indexes | Specific indexes’ data | Low CAR group | High CAR group | χ2 |
<0.33 (n = 78) | >0.33 (n = 64) | |||
Gender | Male | 41 | 39 | 1.00 |
Female | 37 | 25 | ||
Age | ≤60 | 19 | 15 | 0.02 |
>60 | 59 | 49 | ||
Stage | I/II | 45 | 18 | 12.45** |
III/IV | 33 | 46 | ||
Group | A | 66 | 40 | 9.09** |
B | 12 | 24 | ||
IPI-A | Low-medium low risk (0 - 2) | 58 | 26 | 16.56** |
Medium high-high risk (≥3) | 20 | 38 | ||
IPI-B | Low-medium risk (0 - 3) | 73 | 42 | 17.85** |
High risk (≥4) | 5 | 22 | ||
LDH | Normal (109 - 245 U/L) | 53 | 26 | 10.63** |
Increase (>245.0 U/L) | 25 | 38 | ||
β2-MG▲ | Normal (0.80 - 2.20 mg/L) | 34 | 6 | 19.48** |
Increase (>2.2 mg/L) | 20 | 31 | ||
CA125▲ | Normal (0.0 - 35.0 U/ml) | 58 | 29 | 10.18** |
Increase (>35.0 U/ml) | 10 | 20 | ||
Extranodal focus(es) | 1 | 64 | 42 | 5.01* |
≥2 | 14 | 22 | ||
Anemia | Yes | 21 | 40 | 24.42** |
No | 57 | 24 | ||
CRP | Normal (≤10.0 mg/l) | 72 | 0 | 119.84** |
Increase (>10.0 mg/l) | 6 | 64 | ||
ALB | Normal (35.0 - 54.0 g/L) | 69 | 37 | 17.45** |
Decrease (<35.0 g/L) | 9 | 27 |